Evidence map›Paper›PMID 38111901›Full record

ArticleInfluenza and other respiratory viruses2023

Performance of established disease severity scores in predicting severe outcomes among adults hospitalized with influenza-FluSurv-NET, 2017-2018.

Joshua D Doyle, Shikha Garg, Alissa C O'Halloran, Lauren Grant, Evan J Anderson, Kyle P Openo, Nisha B Alden, Rachel Herlihy, James Meek, Kimberly Yousey-Hindes and 17 more

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Joshua D DoyleInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC Atlanta Georgia USA.
Shikha GargInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC Atlanta Georgia USA.
Alissa C O'HalloranInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC Atlanta Georgia USA.
Lauren GrantInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC Atlanta Georgia USA.
Evan J AndersonEmory University School of Medicine Atlanta Georgia USA.
Kyle P OpenoEmory University School of Medicine Atlanta Georgia USA.
Nisha B AldenColorado Department of Public Health and Environment Denver Colorado USA.
Rachel HerlihyColorado Department of Public Health and Environment Denver Colorado USA.
James MeekConnecticut Emerging Infections Program Yale School of Public Health New Haven Connecticut USA.
Kimberly Yousey-HindesConnecticut Emerging Infections Program Yale School of Public Health New Haven Connecticut USA.
Maya L MonroeMaryland Department of Health Baltimore Maryland USA.
Sue KimCommunicable Disease Division, Michigan Department of Health and Human Services Lansing Michigan USA.
Ruth LynfieldMinnesota Department of Health Saint Paul Minnesota USA.
Melissa McMahonMinnesota Department of Health Saint Paul Minnesota USA.
Alison MuseNew York State Department of Health Albany New York USA.
Nancy SpinaNew York State Department of Health Albany New York USA.
Lourdes IrizarryNew Mexico Department of Health Albuquerque New Mexico USA.
Salina TorresNew Mexico Department of Health Albuquerque New Mexico USA.
Nancy M BennettUniversity of Rochester School of Medicine and Dentistry Rochester New York USA.
Maria A GaitanUniversity of Rochester School of Medicine and Dentistry Rochester New York USA.
Mary HillSalt Lake County Health Department Salt Lake City Utah USA.
Charisse N CummingsInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC Atlanta Georgia USA.
Carrie ReedInfluenza Division, National Center for Immunization and Respiratory Diseases, CDC Atlanta Georgia USA.
William SchaffnerVanderbilt University School of Medicine Nashville Tennessee USA.
H Keipp TalbotVanderbilt University School of Medicine Nashville Tennessee USA.
Wesley H SelfVanderbilt University School of Medicine Nashville Tennessee USA.
Derek WilliamsVanderbilt University School of Medicine Nashville Tennessee USA.

Funding

OSTLTS CDC HHS U38 OT000143
6 · The paper itself

Abstract

Background: Influenza is a substantial cause of annual morbidity and mortality; however, correctly identifying those patients at increased risk for severe disease is often challenging. Several severity indices have been developed; however, these scores have not been validated for use in patients with influenza. We evaluated the discrimination of three clinical disease severity scores in predicting severe influenza-associated outcomes. Methods: We used data from the Influenza Hospitalization Surveillance Network to assess outcomes of patients hospitalized with influenza in the United States during the 2017-2018 influenza season. We computed patient scores at admission for three widely used disease severity scores: CURB-65, Quick Sepsis-Related Organ Failure Assessment (qSOFA), and the Pneumonia Severity Index (PSI). We then grouped patients with severe outcomes into four severity tiers, ranging from ICU admission to death, and calculated receiver operating characteristic (ROC) curves for each severity index in predicting these tiers of severe outcomes. Results: Among 8252 patients included in this study, we found that all tested severity scores had higher discrimination for more severe outcomes, including death, and poorer discrimination for less severe outcomes, such as ICU admission. We observed the highest discrimination for PSI against in-hospital mortality, at 0.78. Conclusions: We observed low to moderate discrimination of all three scores in predicting severe outcomes among adults hospitalized with influenza. Given the substantial annual burden of influenza disease in the United States, identifying a prediction index for severe outcomes in adults requiring hospitalization with influenza would be beneficial for patient triage and clinical decision-making.

Indexed as

Influenza, HumanPneumoniaAdultHospitalizationHumansIntensive Care UnitsPatient AcuityPrognosisRetrospective StudiesROC CurveSeverity of Illness Indexdisease severityhospitalizationinfluenzamortality

Identifiers

PMID38111901
PMCPMC10725795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.